Insider Transactions last 24 months for CytomX Therapeutics, Inc.  -  NSDQ: CTMX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Mccarthy Sean A.CEO06/16/2025DSDirectCOM55,511$2.69$149,263.531,089,684
Belvin MarciaSVP, Chief Scientific Officer06/16/2025DSDirectCOM13,884$2.69$37,334.08272,252
Ogden ChristopherChief Financial Officer06/16/2025DSDirectCOM10,614$2.69$28,539.98226,271
Mccarthy Sean A.CEO06/13/2025AMDirectCOM150,000$0.00$0.001,145,195
Belvin MarciaSVP, Chief Scientific Officer06/13/2025AMDirectCOM37,500$0.00$0.00286,136
Ogden ChristopherChief Financial Officer06/13/2025AMDirectCOM37,500$0.00$0.00236,885
Ogden ChristopherChief Financial Officer06/13/2025DSDirectCOM1,641$2.95$4,841.44199,385
Belvin MarciaSVP, Chief Scientific Officer03/18/2025DSDirectCOM19,512$0.60$11,687.69248,636
Rowland Lloyd AGeneral Counsel03/18/2025DSDirectCOM10,203$0.60$6,111.60120,594
Chu Yu-WayeChief Medical Officer03/18/2025DSDirectCOM4,025$0.60$2,410.98135,725
Ogden ChristopherChief Financial Officer03/18/2025DSDirectCOM8,551$0.60$5,122.05201,026
Mccarthy Sean A.CEO03/18/2025DSDirectCOM37,656$0.60$22,555.94995,195
Mccarthy Sean A.CEO02/04/2025AADirectCOM195,000$0.00$0.001,032,851
Mccarthy Sean A.CEO02/04/2025AADirectCOM180,000$0.00$0.00837,851
Ogden ChristopherChief Financial Officer02/04/2025AADirectCOM57,500$0.00$0.00209,577
Ogden ChristopherChief Financial Officer02/04/2025AADirectCOM44,000$0.00$0.00152,077
Chu Yu-WayeChief Medical Officer02/04/2025AADirectCOM57,500$0.00$0.00139,750
Chu Yu-WayeChief Medical Officer02/04/2025AADirectCOM56,000$0.00$0.0082,250
Belvin MarciaSVP, Chief Scientific Officer02/04/2025AADirectCOM57,500$0.00$0.00263,148
Belvin MarciaSVP, Chief Scientific Officer02/04/2025AADirectCOM30,000$0.00$0.00205,648
Mccarthy Sean A.CEO08/20/2024DSDirectCOM13,898$1.23$17,082.03657,851
Mccarthy Sean A.CEO08/20/2024AMDirectCOM37,500$0.00$0.00671,749
Ogden ChristopherChief Financial Officer08/20/2024DSDirectCOM1,984$1.23$2,438.53108,077
Ogden ChristopherChief Financial Officer08/20/2024AMDirectCOM6,875$0.00$0.00110,061
Rowland Lloyd AGeneral Counsel08/20/2024DSDirectCOM4,181$1.23$5,138.87130,797
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel